American depository receipts of European stocks were 0.03% higher at 134.24 on the Bank of New York Mellon Europe ADR Index on Thursday morning. Gainers in Continental Europe were led by Criteo (CRTO), a French technology company, 3.3% higher, followed by Nabriva Therapeutics (NBRV), an Austria-based clinical-stage biopharmaceutical company, up by 3.1% and Cellectis (CLLS), a French genome engineering company, 1.7% higher. TiGenix (TIG), a Belgium-based biopharmaceutical company, was up by 1.5%.
In the UK, Shire (SHPG), a biopharmaceutical company, was 4.7% higher, followed by Royal Bank of Scotland (RBS), up by 3% and Trinity Biotech (TRIB), a manufacturer of medical diagnostic products, up by 2.8%. Barclays Bank (BCS) was 2.3% higher. Decliners in Continental Europe were led by Telecom Italia (TI), down by 3.5%, followed by CGG (CGG), a manufacturer of geophysical equipment, 3.1% lower and Banco Santander (SAN) and AB InBev (BUD), a Belgium-based company engaged in the brewers industry, both 2.7% lower.